Cramer C M, Hubbell C L, Reid L D
Laboratory for Psychopharmacology, Rensselaer Polytechnic Institute, Troy, NY 12180-3590, USA.
Pharmacol Biochem Behav. 1998 Aug;60(4):847-53. doi: 10.1016/s0091-3057(98)00063-x.
Rats were conditioned by pairing cocaine with one side of an alley and placebo with the other. After conditioning, compared to Baseline and a placebo-control group, rats spent more time in the place of cocaine experience. Subsequently, there were further tests except now cocaine was given just before the test session in addition to one of two other kinds of injections. One of these additional injections was a placebo and the other was a combination of a small dose of isradipine (1 mg/kg) and a dose of naltrexone (3 mg/kg) (ISR + NTX). Measures of gross activity (movement from one side of the alley to the other) were taken during testing. ISR + NTX blocked cocaine's ability to sustain a place preference. ISR + NTX also blocked sensitization of cocaine's ability to enhance locomotor activity. This blockade of cocaine's usual effects indicates that ISR + NTX may have a role in treating cocaine use disorders.
通过将可卡因与通道的一侧配对,安慰剂与另一侧配对来对大鼠进行条件训练。条件训练后,与基线和安慰剂对照组相比,大鼠在有可卡因体验的地方停留的时间更长。随后,进行了进一步的测试,不过现在除了另外两种注射中的一种外,在测试前还给予可卡因。这两种额外注射中的一种是安慰剂,另一种是小剂量的伊拉地平(1毫克/千克)和一剂纳曲酮(3毫克/千克)的组合(伊拉地平+纳曲酮)。在测试期间测量总体活动(从通道一侧移动到另一侧)。伊拉地平+纳曲酮阻断了可卡因维持位置偏好的能力。伊拉地平+纳曲酮还阻断了可卡因增强运动活动能力的敏化作用。对可卡因通常作用的这种阻断表明伊拉地平+纳曲酮可能在治疗可卡因使用障碍中发挥作用。